Rational Advisors LLC Abb Vie Inc. Transaction History

Rational Advisors LLC

$940 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $228,005 - $266,259	1,473 New	1,473 $252,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.64 Million - $1.89 Million	-11,347 Reduced 98.37%	188 $29,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $529,450 - $634,950	-3,828 Reduced 24.92%	11,535 $1.86 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $387,061 - $443,934	2,884 Added 23.11%	15,363 $2.06 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $1.69 Million - $2.15 Million	12,297 Added 6756.59%	12,479 $1.91 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $1.19 Million - $1.48 Million	-9,015 Reduced 98.02%	182 $30,000
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $564,544 - $714,312	-5,255 Reduced 36.36%	9,197 $1.25 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $386,657 - $438,914	3,634 Added 33.59%	14,452 $1.56 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $198,846 - $221,526	-1,890 Reduced 14.87%	10,818 $1.22 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $218,205 - $240,218	2,133 Added 20.17%	12,708 $1.38 Million
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $170,638 - $230,380	-2,120 Reduced 16.7%	10,575 $1.13 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $40,377 - $47,390	-470 Reduced 3.57%	12,695 $1.11 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $965,916 - $1.29 Million	13,165 New	13,165 $1.29 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $485,620 - $736,260	-7,529 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $339,299 - $424,536	4,704 Added 166.51%	7,529 $666,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $13,603 - $16,355	-216 Reduced 7.1%	2,825 $213,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $90,731 - $115,976	1,381 Added 83.19%	3,041 $221,000
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $101,747 - $119,752	-1,319 Reduced 44.28%	1,660 $134,000
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $243,592 - $300,415	-3,129 Reduced 51.23%	2,979 $275,000
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $452,996 - $503,589	5,095 Added 502.96%	6,108 $578,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $76,133 - $90,083	848 Added 513.94%	1,013 $94,000
Q1 2018 May 18, 2018	BUY	$92.01 - $123.21 $15,181 - $20,329	165 New	165 $16,000
Q4 2017 Feb 08, 2018	SELL	$89.56 - $98.21 $277,636 - $304,451	-3,100 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $216,534 - $276,582	3,100	3,100 $275,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rational Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rational Advisors LLC with notifications on news.

Account